Pilot trial of a WT-1 analog peptide vaccine in patients with thoracic and myeloid neoplasms
Phase of Trial: Phase I
Latest Information Update: 07 Mar 2016
At a glance
- Drugs INNO 305 (Primary) ; Montanide ISA-51; Sargramostim
- Indications Acute myeloid leukaemia; Mesothelioma; Myelodysplastic syndromes; Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 15 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Jan 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.